EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Pembrolizumab-Induced Eruptive Keratoacanthomas Managed With Intralesional Corticosteroids: A Case Report

Kevin Varghese, Develyn Vetos, Jason Woods, Jesalyn Tate, Ting Wang-Weinman

Cureus · 03.05.2026

DOI: 10.7759/cureus.108171 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 03.05.2026. Verfasst von Kevin Varghese und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, University of Kansas Medical Center, Kansas City, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

dermatology and dermatologic surgeryimmune-mediated adverse eventsnonmelanoma skin cancerpd-1 inhibitorsscc-squamous cell carcinoma

Autor:innen und Institutionen

  • Dermatology, University of Kansas Medical Center, Kansas City, USA.

Zitieren

APA

Varghese, K., Vetos, D., Woods, J., Tate, J., & Wang-Weinman, T. (2026). Pembrolizumab-Induced Eruptive Keratoacanthomas Managed With Intralesional Corticosteroids: A Case Report. Cureus. https://doi.org/10.7759/cureus.108171

Vancouver

Varghese K, Vetos D, Woods J, Tate J, Wang-Weinman T. Pembrolizumab-Induced Eruptive Keratoacanthomas Managed With Intralesional Corticosteroids: A Case Report. Cureus. 2026. doi:10.7759/cureus.108171

BibTeX
@article{Varghese2026,
  author = {Varghese, Kevin and Vetos, Develyn and Woods, Jason and Tate, Jesalyn and Wang-Weinman, Ting},
  title = {Pembrolizumab-Induced Eruptive Keratoacanthomas Managed With Intralesional Corticosteroids: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.108171}
}
Kostenlos starten →